Viktor Bugajev

430 total citations
16 papers, 367 citations indexed

About

Viktor Bugajev is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Viktor Bugajev has authored 16 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Viktor Bugajev's work include Mast cells and histamine (11 papers), Sphingolipid Metabolism and Signaling (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Viktor Bugajev is often cited by papers focused on Mast cells and histamine (11 papers), Sphingolipid Metabolism and Signaling (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Viktor Bugajev collaborates with scholars based in Czechia, Russia and United States. Viktor Bugajev's co-authors include Petr Dráber, Lubica Dráberová, Monika Bambousková, Ivana Hálová, Václav Hořejšı́, Bridget S. Wilson, Bernard Malissen, Iva Polakovičová, Petr Heneberg and S̆árka S̆ı́mová and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Viktor Bugajev

16 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viktor Bugajev Czechia 10 245 166 55 52 50 16 367
Colleen Davenport United States 8 341 1.4× 173 1.0× 52 0.9× 89 1.7× 11 0.2× 13 425
Ralph Jans United States 11 63 0.3× 189 1.1× 17 0.3× 34 0.7× 7 0.1× 12 338
Judith L. Scott Australia 8 138 0.6× 128 0.8× 89 1.6× 28 0.5× 21 0.4× 9 388
Jaekwang Jeong United States 11 67 0.3× 200 1.2× 21 0.4× 16 0.3× 49 1.0× 19 395
H. Koizumi Japan 10 52 0.2× 188 1.1× 21 0.4× 38 0.7× 12 0.2× 27 348
Stephanie Everingham Canada 9 112 0.5× 237 1.4× 27 0.5× 26 0.5× 4 0.1× 9 353
M Buchholz United States 10 281 1.1× 237 1.4× 7 0.1× 43 0.8× 8 0.2× 14 520
S.H. Kidson South Africa 14 48 0.2× 164 1.0× 15 0.3× 16 0.3× 34 0.7× 23 387
Thomas Wilhelm Germany 10 69 0.3× 162 1.0× 14 0.3× 17 0.3× 19 0.4× 20 334
Aref G. Ebrahimi United States 7 100 0.4× 135 0.8× 35 0.6× 67 1.3× 5 0.1× 8 366

Countries citing papers authored by Viktor Bugajev

Since Specialization
Citations

This map shows the geographic impact of Viktor Bugajev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Bugajev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Bugajev more than expected).

Fields of papers citing papers by Viktor Bugajev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktor Bugajev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Bugajev. The network helps show where Viktor Bugajev may publish in the future.

Co-authorship network of co-authors of Viktor Bugajev

This figure shows the co-authorship network connecting the top 25 collaborators of Viktor Bugajev. A scholar is included among the top collaborators of Viktor Bugajev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktor Bugajev. Viktor Bugajev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bugajev, Viktor, et al.. (2023). Simultaneous reduction of all ORMDL proteins decreases the threshold of mast cell activation. Scientific Reports. 13(1). 9615–9615. 5 indexed citations
2.
Bugajev, Viktor, et al.. (2023). Enhanced Membrane Fluidization and Cholesterol Displacement by 1-Heptanol Inhibit Mast Cell Effector Functions. Cells. 12(16). 2069–2069. 1 indexed citations
3.
Shaik, Gouse M., et al.. (2022). Pentacyclic triterpenoid ursolic acid interferes with mast cell activation via a lipid-centric mechanism affecting FcεRI signalosome functions. Journal of Biological Chemistry. 298(11). 102497–102497. 3 indexed citations
4.
Bugajev, Viktor, Ivana Hálová, Ladislav Kuchař, et al.. (2021). Crosstalk between ORMDL3, serine palmitoyltransferase, and 5-lipoxygenase in the sphingolipid and eicosanoid metabolic pathways. Journal of Lipid Research. 62. 100121–100121. 7 indexed citations
5.
Bugajev, Viktor, Ivana Hálová, Lubica Dráberová, et al.. (2021). ORMDL2 Deficiency Potentiates the ORMDL3-Dependent Changes in Mast Cell Signaling. Frontiers in Immunology. 11. 591975–591975. 10 indexed citations
6.
Dráber, Petr, Ivana Hálová, Ladislav Kuchař, et al.. (2020). Production of leukotriene signaling mediators is limited by ORMDL3/serine palmitoyltransferase/5-lipoxygenase crosstalk. The Journal of Immunology. 204(1_Supplement). 152.18–152.18. 1 indexed citations
7.
Paluchová, Veronika, Anders Vik, Tomáš Čajka, et al.. (2020). Triacylglycerol‐Rich Oils of Marine Origin are Optimal Nutrients for Induction of Polyunsaturated Docosahexaenoic Acid Ester of Hydroxy Linoleic Acid (13‐DHAHLA) with Anti‐Inflammatory Properties in Mice. Molecular Nutrition & Food Research. 64(11). e1901238–e1901238. 33 indexed citations
8.
Hálová, Ivana, Monika Bambousková, Lubica Dráberová, Viktor Bugajev, & Petr Dráber. (2018). The transmembrane adaptor protein NTAL limits mast cell chemotaxis toward prostaglandin E 2. Science Signaling. 11(556). 4 indexed citations
9.
Bambousková, Monika, Iva Polakovičová, Ivana Hálová, et al.. (2016). New Regulatory Roles of Galectin-3 in High-Affinity IgE Receptor Signaling. Molecular and Cellular Biology. 36(9). 1366–1382. 25 indexed citations
10.
Bugajev, Viktor, Ivana Hálová, Lubica Dráberová, et al.. (2015). Negative regulatory roles of ORMDL3 in the FcεRI-triggered expression of proinflammatory mediators and chemotactic response in murine mast cells. Cellular and Molecular Life Sciences. 73(6). 1265–1285. 26 indexed citations
11.
12.
Dráberová, Lubica, Viktor Bugajev, Ivana Hálová, et al.. (2014). Transmembrane Adaptor Protein PAG/CBP Is Involved in both Positive and Negative Regulation of Mast Cell Signaling. Molecular and Cellular Biology. 34(23). 4285–4300. 22 indexed citations
13.
Draberova, Helena, Iva Polakovičová, Gouse M. Shaik, et al.. (2011). 1,2-propanediol-trehalose mixture as a potent quantitative real-time PCR enhancer. BMC Biotechnology. 11(1). 41–41. 34 indexed citations
14.
Bugajev, Viktor, Monika Bambousková, Lubica Dráberová, & Petr Dráber. (2010). What precedes the initial tyrosine phosphorylation of the high affinity IgE receptor in antigen‐activated mast cell?. FEBS Letters. 584(24). 4949–4955. 30 indexed citations
15.
Hájková, Zuzana, Viktor Bugajev, Eduarda Dráberová, et al.. (2010). STIM1-Directed Reorganization of Microtubules in Activated Mast Cells. The Journal of Immunology. 186(2). 913–923. 40 indexed citations
16.
Dráberová, Lubica, S̆árka S̆ı́mová, Petr Heneberg, et al.. (2004). Negative Regulation of Mast Cell Signaling and Function by the Adaptor LAB/NTAL. The Journal of Experimental Medicine. 200(8). 1001–1014. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026